Bianca Seminotti

Bianca Seminotti

Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in Brain Research
Verified
Journal Article
Closed access
AAAlexandre Umpierrez Amaral
Alexandre Umpierrez Amaral
GLGuilhian Leipnitz
Guilhian Leipnitz
CFCarolina Gonçalves Fernandes
Carolina Gonçalves Fernandes
BSBianca Seminotti
Bianca Seminotti
PSPatrícia Fernanda Schuck
Patrícia Fernanda Schuck
MWMoacir Wajner
Moacir Wajner

23 September 2009 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
CFCarolina G. Fernandes
Carolina G. Fernandes
GLGuilhian Leipnitz
Guilhian Leipnitz
BSBianca Seminotti
Bianca Seminotti
AAAlexandre U. Amaral
Alexandre U. Amaral
ÂZÂngela Zanatta
Ângela Zanatta
MWMoacir Wajner
Moacir Wajner

18 January 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GLGuilhian Leipnitz
Guilhian Leipnitz
AMAl-Walid Mohsen
Al-Walid Mohsen
AKAnuradha Karunanidhi
Anuradha Karunanidhi
BSBianca Seminotti
Bianca Seminotti
VRVera Y. Roginskaya
Vera Y. Roginskaya
JVJerry Vockley
Jerry Vockley
Mitochondrial complex I (CI) deficiency is the most frequent cause of oxidative phosphorylation (OXPHOS) disorders in humans. In order to benchmark the effects of CI deficiency on mitochondrial bioenergetics and dynamics, respiratory chain (RC) and endoplasmic reticulum (ER)-mitochondria communication, and superoxide production, fibroblasts from patients with mutations in the ND6, NDUFV1 or ACAD9 genes were analyzed. Fatty acid metabolism, basal and maximal respiration, mitochondrial membrane potential, and ATP levels were decreased. Changes in proteins involved in mitochondrial dynamics were detected in various combinations in each cell line, while variable changes in RC components were observed. ACAD9 deficient cells exhibited an increase in RC complex subunits and DDIT3, an ER stress marker. The level of proteins involved in ER-mitochondria communication was decreased in ND6 and ACAD9 deficient cells. |ΔΨ| and cell viability were further decreased in all cell lines. These findings suggest that disruption of mitochondrial bioenergetics and dynamics, ER-mitochondria crosstalk, and increased superoxide contribute to the pathophysiology in patients with ACAD9 deficiency. Furthermore, treatment of ACAD9 deficient cells with JP4-039, a novel mitochondria-targeted reactive oxygen species, electron and radical scavenger, decreased superoxide level and increased basal and maximal respiratory rate, identifying a potential therapeutic intervention opportunity in CI deficiency.

16 November 2018 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
BSBianca Seminotti
Bianca Seminotti
GLGuilhian Leipnitz
Guilhian Leipnitz
AKAnuradha Karunanidhi
Anuradha Karunanidhi
CKCatherine Kochersperger
Catherine Kochersperger
VRVera Y Roginskaya
Vera Y Roginskaya
JVJerry Vockley
Jerry Vockley
Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is the most common defect of mitochondrial long-chain fatty acid β-oxidation. Patients present with heterogeneous clinical phenotypes affecting heart, liver and skeletal muscle predominantly. The full pathophysiology of the disease is unclear and patient response to current therapeutic regimens is incomplete. To identify additional cellular alterations and explore more effective therapies, mitochondrial bioenergetics and redox homeostasis were assessed in VLCAD-deficient fibroblasts, and several protective compounds were evaluated. The results revealed cellular and tissue changes, including decreased respiratory chain (RC) function, increased reactive oxygen species (ROS) production and altered mitochondrial function and signaling pathways in a variety of VLCAD-deficient fibroblasts. The mitochondrially enriched electron and free radical scavengers JP4-039 and XJB-5-131 improved RC function and decreased ROS production significantly, suggesting that they are viable candidate compounds to further develop to treat VLCAD-deficient patients.

22 March 2011 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
CFCarolina Gonçalves Fernandes
Carolina Gonçalves Fernandes
CBClarissa Günther Borges
Clarissa Günther Borges
BSBianca Seminotti
Bianca Seminotti
AAAlexandre Umpierrez Amaral
Alexandre Umpierrez Amaral
LKLisiane Aurélio Knebel
Lisiane Aurélio Knebel
MWMoacir Wajner
Moacir Wajner

1 March 2008 in Life Sciences
Verified
Journal Article
Closed access
GLGuilhian Leipnitz
Guilhian Leipnitz
BSBianca Seminotti
Bianca Seminotti
AAAlexandre U. Amaral
Alexandre U. Amaral
GBGiorgia de Bortoli
Giorgia de Bortoli
ASAlexandre Solano
Alexandre Solano
MWMoacir Wajner
Moacir Wajner